Daniel Rueda-rekin lankidetzan egindako argitalpenak (4)

2015

  1. Conversion, correction, and international scale standardization: Results from a multicenter external quality assessment study for BCR-ABL1 testing

    Archives of Pathology and Laboratory Medicine, Vol. 139, Núm. 4, pp. 522-529

2013

  1. Inhibition of related JAK/STAT pathways with molecular targeted drugs shows strong synergy with ruxolitinib in chronic myeloproliferative neoplasm

    British Journal of Haematology, Vol. 161, Núm. 5, pp. 667-676

2012

  1. Use of Sorafenib as an effective treatment in an AML patient carrying a new point mutation affecting the Juxtamembrane domain of FLT3

    British Journal of Haematology

2011

  1. Differential expression of JAK2 and Src kinase genes in response to hydroxyurea treatment in polycythemia vera and essential thrombocythemia

    Annals of Hematology, Vol. 90, Núm. 8, pp. 939-946